VC

Vikas Chaudhary

Active Director Director DIN 10832747
DIN 10832747 First appointment Nov 2025 Primary industry E-Commerce
Unlock full profile Investments · shareholding · contact details
Current companies 1 active board seats
Total affiliations 1 Since Nov 2025
Shareholding value •••• Premium profile

About Vikas Chaudhary

Data last updated:

Vikas Chaudhary is a Director at Endoshine Pharmaceuticals Private Limited (since 2025). The company operates in E-Commerce. Endoshine Pharmaceuticals Private Limited reported revenue of ₹22,100 (FY 2022).

DIN 10832747
Primary Designation Director
Industry E-Commerce
First Appointment 17 Nov 2025
Largest company Endoshine Pharmaceuticals Private Limited · ₹22,100 (FY 2022)

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Director17 Nov 2025₹22,100 (FY 2022)Active

Board colleagues of Vikas Chaudhary

Directorship timeline

Open interactive timeline →
Endoshine Pharmaceuticals Private Limited
Premium access

Shareholding and investment profile for Vikas Chaudhary

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Vikas Chaudhary

Vikas Chaudhary currently holds 1 directorship: Endoshine Pharmaceuticals Private Limited (Director, since 17 Nov 2025, revenue ₹22,100 (FY 2022)).

Vikas Chaudhary was first appointed on 17 Nov 2025 as Director at Endoshine Pharmaceuticals Private Limited.

The current boards of Vikas Chaudhary's companies include Rahul Singhal (Endoshine Pharmaceuticals Private Limited), Sajal Singhal (Endoshine Pharmaceuticals Private Limited).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available